PF-06863135
PF-06863135 Uses, Dosage, Side Effects, Food Interaction and all others data.
PF-06863135 is under investigation in clinical trial NCT03269136 (Phase 1 Study Of PF-06863135, A BCMA- CD3 Bispecific Ab, In Relapse/ Refractory Multiple Myeloma).
| Trade Name | PF-06863135 |
| Generic | PF-06863135 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here PF-06863135
